Isolated positive deamidated gliadin peptide‐IgG has limited diagnostic utility in coeliac disease

AIM: Deamidated gliadin peptide‐IgG (DGP‐IgG) antibody serology testing is widely utilised in screening for coeliac disease in Australia; however, it is used sparingly in Europe. The aim of this study was to assess the diagnostic value of a positive DGP‐IgG in the setting of a negative tissue transg...

Descripción completa

Detalles Bibliográficos
Autores principales: Vootukuru, Nikil, Singh, Harveen, Giles, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545789/
https://www.ncbi.nlm.nih.gov/pubmed/35726522
http://dx.doi.org/10.1111/jpc.16071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545789/
https://www.ncbi.nlm.nih.gov/pubmed/35726522
http://dx.doi.org/10.1111/jpc.16071

Ejemplares similares